2025-10-24 - Analysis Report
Okay, here's an analysis of Lam Research Corp (LRCX) based on the data you provided.

**Report on Lam Research Corp (LRCX)**

Lam Research Corp. is a global supplier of wafer fabrication equipment and services to the semiconductor industry.

**1. Performance vs. S&P 500 (VOO)**

*   **Cumulative Return (LRCX):** 229.15%
*   **Cumulative Return (VOO):** 99.09%
*   **Absolute Spread:** 139.6 (LRCX significantly outperformed VOO)
*   **Spread Range:** Max 155.3, Min -15.5
*   **Relative Spread:** 90.8 (Indicates LRCX's outperformance is near the high end of its historical range compared to VOO)

**Alpha, Beta Analysis:**

| Year      | CAGR    | MDD     | Alpha   | Beta  | Cap(B) |
| :---------- | :------ | :------ | :------ | :---- | :------- |
| 2015-2017 | 88.0%   | 77.6%   | 60.0%   | 0.1   | 23.6   |
| 2016-2018 | 16.0%   | 68.1%   | 1.0%    | 0.1   | 17.5   |
| 2017-2019 | 52.0%   | 83.0%   | 30.0%   | 1.0   | 37.5   |
| 2018-2020 | 66.0%   | 83.0%   | 42.0%   | 1.0   | 60.6   |
| 2019-2021 | 120.0%  | 83.0%   | 74.0%   | 1.0   | 92.2   |
| 2020-2022 | -10.0%  | 79.1%   | -9.0%   | 0.9   | 53.9   |
| 2021-2023 | -14.0%  | 80.4%   | -15.0%  | 0.9   | 100.5  |
| 2022-2024 | -53.0%  | 80.4%   | -74.0%  | 1.0   | 92.7   |
| 2023-2025 | 138.0%  | 80.4%   | 74.0%   | 0.9   | 186.1  |

*   **CAGR:**  Shows strong growth in some periods (2015-2017, 2019-2021, 2023-2025), but significant declines in others (2020-2022, 2021-2024).
*   **MDD (Maximum Drawdown):**  High MDD values across all periods, indicating significant volatility.
*   **Alpha:** Varies greatly.  Positive alpha indicates outperformance relative to the market (VOO), while negative alpha indicates underperformance.
*   **Beta:** Generally around 1.0, suggesting the stock's volatility is similar to the market.  A beta of 0.1 in some periods indicates lower sensitivity to the market during those times.
*   **Cap(B):** The market capitalization has fluctuated, recently increasing to 186.1B.

**2. Recent Price Action**

*   **Current Price:** 145.04
*   **Last Market Data:**
    *   Price: 147.54
    *   Previous Close: 141.25
    *   Change: 4.45 (Significant positive change)
*   **Moving Averages:**
    *   5-day: 143.55
    *   20-day: 138.80
    *   60-day: 116.92

**Analysis:**  The price is above all three moving averages, indicating an uptrend. The large change in the last market data suggests strong positive momentum.

**3. Market Risk Indicators and Expected Return**

*   **MRI (Market Risk Indicator):** 0.9 (Medium Investment Recommended). This suggests moderate risk, leaning towards a favorable investment environment.
*   **RSI (Relative Strength Index):** 52.20.  This is a neutral reading, neither overbought nor oversold.
*   **PPO (Percentage Price Oscillator):** -0.6412.  A negative value suggests the short-term moving average is below the long-term moving average, potentially indicating a weakening trend or consolidation.
*   **Hybrid Signal:** cash_80%_Sell 80.0% of holdings (2422 shares - Risky - MRI:0.50) (Cash Ratio: 80% on 2025-10-16). This is a strong sell signal, advising to reduce holdings significantly, driven by risk concerns and a lower MRI.
*   **Recent (20-day) Relative Spread Change:** 12.3 (+).  Indicates short-term positive momentum relative to the S&P 500.
*   **Expected Return:** 17.6%.  Projected excess return over the S&P 500 with a long-term (2+ year) investment.

**4. Recent News & Significant Events**

*   **Analyst Reports:** Multiple analyst reports from Morningstar and Argus Research (dated 2025-10-23) suggest recent coverage and potential catalysts for price movement.
*   **Market Update:** LRCX mentioned in an Argus Research market update (2025-10-23), likely discussing recent performance or outlook.
*   **US Equity Indexes Advance:** General positive market sentiment might be influencing LRCX.

**4-2. Analyst Opinions**

*   **Consensus:** Buy (Mean: 1.74)
*   **Number of Opinions:** 30
*   **Target Price:**
    *   Average: 154.86
    *   High: 200.00
    *   Low: 84.00

**Analysis:** Analysts are generally positive on LRCX with a Buy consensus and an average target price above the current price. The wide range in target prices suggests some uncertainty in the outlook.

**5. Recent Earnings Analysis**

| 날짜       | EPS  | 매출      |
| :----------- | :--- | :-------- |
| 2025-04-25 | 1.04 | 4.72 B$   |
| 2025-01-31 | 0.93 | 4.38 B$   |
| 2024-10-28 | 0.86 | 4.17 B$   |
| 2024-01-29 | 7.25 | 3.76 B$   |
| 2025-01-31 | 0.72 | 3.76 B$   |

**Analysis:** The provided data shows fluctuation in EPS and revenue. The EPS dropped significantly in 2025 but started recovering. The strong EPS figure in 2024 might skew historical comparisons.

**6. Financial Information**

| Quarter    | Revenue | Profit Margin |
| :--------- | :-------- | :-------------- |
| 2025-06-30 | $5.17B  | 50.08%          |
| 2025-03-31 | $4.72B  | 49.02%          |
| 2024-12-31 | $4.38B  | 47.37%          |
| 2024-09-30 | $4.17B  | 48.05%          |
| 2024-06-30 | $3.87B  | 47.53%          |

| Quarter    | Equity    | ROE      |
| :--------- | :---------- | :------- |
| 2025-06-30 | $9.86B    | 17.44%   |
| 2025-03-31 | $9.51B    | 13.99%   |
| 2024-12-31 | $8.81B    | 13.52%   |
| 2024-09-30 | $8.47B    | 13.18%   |
| 2024-06-30 | $8.54B    | 11.95%   |

**Analysis:**

*   **Revenue and Profit Margin:** Revenue is increasing steadily, and the profit margin is relatively stable and high, indicating strong profitability.
*   **Equity and ROE (Return on Equity):** Equity is increasing, and ROE is also increasing, showing improved profitability and efficient use of shareholder equity.

**7. Overall Assessment**

Lam Research Corp. (LRCX) demonstrates strong historical outperformance compared to the S&P 500 (VOO). Recent data reveals a mixed picture:

*   **Positives:**
    *   Strong recent price momentum.
    *   Revenue, Equity, and ROE growth are positive.
    *   High and relatively stable profit margins.
    *   Positive analyst consensus and average target price.
    *   High Expected Return.
*   **Negatives:**
    *   High MDD indicates a highly volatile stock.
    *   Hybrid Signal (cash_80%_Sell) recommends selling.
    *   RSI is in the neutral zone, while the PPO indicates short-term weakness.
    *   Fluctuations in EPS, with a drop in the most recent quarters.

**Recommendation:**

The data presents a complex picture. The company appears fundamentally strong with increasing revenue and profitability.  However, the significant sell signal and the high volatility warrant caution.

**Disclaimer:** This analysis is based solely on the provided data and does not constitute financial advice. Investors should conduct their own research and consider their individual risk tolerance before making any investment decisions.
